[go: up one dir, main page]

WO2004078695A1 - Method for the purification of crocetin - Google Patents

Method for the purification of crocetin Download PDF

Info

Publication number
WO2004078695A1
WO2004078695A1 PCT/JP2004/002693 JP2004002693W WO2004078695A1 WO 2004078695 A1 WO2004078695 A1 WO 2004078695A1 JP 2004002693 W JP2004002693 W JP 2004002693W WO 2004078695 A1 WO2004078695 A1 WO 2004078695A1
Authority
WO
WIPO (PCT)
Prior art keywords
crocetin
solvent
purification
crocin
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2004/002693
Other languages
French (fr)
Inventor
Masahiro Takahashi
Koichi Harada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riken Vitamin Co Ltd
Original Assignee
Riken Vitamin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken Vitamin Co Ltd filed Critical Riken Vitamin Co Ltd
Publication of WO2004078695A1 publication Critical patent/WO2004078695A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/43Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/42Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Definitions

  • the present invention relates to a method for the purification of crocetin which is obtained by hydrolysis of crocin existing in a plant extract.
  • Crocin which is extracted from dried fruits of gardenia or fromdried saffron stigma, is digentiobiose ester of crocetin. Crocetin is obtained by hydrolyzing crocin with alkali, etc. to remove digentiobiose of crocin (c.f . , for example, non-patent literature 1 ) .
  • Crocin is water-soluble and used as a primary color component of gardenia yellow for coloring a wide range of foods in Japan.
  • crocetin is insoluble in water and soluble in diluted alkaline water, and thus it has been limitedly used as a coloring agent for Chinese noodle (c.f., for example, patent literature 2) or soft drinks (c.f., for example, patent literature 3), etc.
  • crocetin of high purity prepared not only byhydrolysis of crocin but alsobytheremoval of impurities forpurification is desired.
  • Patent literature 1 Japanese Unexamined Patent Publication No. H07-018194
  • Patent literature 2 Japanese Unexamined Patent Publication No. S54-064652
  • Patent literature 3 Japanese Unexamined Patent Publication No. H06-248193
  • Patent literature 4 Japanese Unexamined Patent Publication No. H05-320036
  • Patent literature 5 Japanese Unexamined Patent Publication No. H07-285846 (Patent literature 6) Japanese Unexamined Patent Publication No. Hll-246396
  • Non-patent literature 2 KON Masayo, "gardenia carotenoidpigment” , Bulletin of FukuokaWomen' s JuniorCollege, 1999, No. 57, p.31-34
  • Non-patent literature 3 KAMIKURAMieko, et al. , "Journal of the Food Hygienic Society of Japan", 1985, 26, No.2, p.151 (Non-patent literature 4) J.Agric.Food Chem. , 1996, 44, No.9, p.2613, left column, line46-61
  • Non-patent literature 5 SpectrochemicaActaPart A, 1998, 54, p.654, left column, lines 16-24 (Non-patent literature 6) J.Food Sci.Technol. , 2001, 38, No.4, p.325, left column, lines 36-42
  • An object of the present invention is to provide an easily operated, industrially advantageous method for the production of crocetin.
  • the present inventors had conducted intensive investigations to solve the above mentioned problems and, as a result, they have found that a desired crocetin of high purity canbe effectivelypreparedwhen crocetin containing impurities , which is obtained by hydrolysis of crocin existing in a plant extract, is treated with a specific organic solvent. Based on this finding, the present inventors have achieved the present invention.
  • the present invention relates to the following (1) to (9).
  • a method for the purification of crocetin which comprises the steps of (a) treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol; and (b) removing a soluble component in the solvent.
  • a method for the purification of crocetin which comprises the steps of (a) treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol to remove a soluble component in the solvent; and (b) crystallizing the above treated crocetin from an aprotic solvent which can crystallize crocetin.
  • a cosmetic product or pharmaceutical composition which comprises the purified crocetin described in the above
  • Crocin which is ayellow carotenoid pigment , is contained in dried fruits of gardenia (rubiaceae) (Gardenia augusta ERRIL var. grandiflora HORT., Gardenia jasminoides ELLIS) and dried saffron stigma, and the fruits of gardenia are preferably used as an industrial material to obtain crocin.
  • crocin is extracted frompulverized, driedfruits of gardeniawithwater or an alcohol or a mixture thereof .
  • water is pre erable as an extracting solvent, the extraction rate is low.
  • amixture ofwater andan alcohol is usedfor industrial purposes .
  • the alcohol include ethanol, methanol and the like, among which methanol is preferably used.
  • the preferable mixing ratio of an alcohol relative to the mixture of the alcohol and water is, for example, not less than 50% by volume.
  • the extract is collected all together and filtered through filter paper or filter cloth optionally using a filter aid such as diatomite .
  • the filtrate is concentrated to recover alcohol, whereby a concentrate can be obtained.
  • an iridoid glycoside such as geniposide, etc. from the extract of gardenia by absorbent resin treatment or membrane separation treatment, etc.
  • Absorbent resin treatment is carried out in such a manner that acolumnis filledwithaporous absorbent andthe concentrate which is diluted to the appropriate concentration is supplied to the column.
  • a pigment solution i.e. the above diluted concentrate containing crocin
  • impurities are washed out with water or a mixture of a dilute alcohol and water.
  • the pigments were desorbed i.e. eluted by 50 to 70 % by volume of alcohol and the eluted solution is concentrated to give a concentrate in which geniposide is significantly reduced.
  • Examples of the alcohol include a lower alcohol having 1 to 4 carbon atoms such as methanol, ethanol, propanol, isopropanol, n-butanol, i-butanol, sec-butanol, tert-butanol, etc., among which ethanol is preferably used.
  • Examples of the porous absorbent include Amberlite XAD-4, Jlmberlite XAD-7 (Trademark: Organo Corporation), Diaion HP-20, HP-21, HP-40 (Trademark: Mitsubishi Chemical Corporation), and the like.
  • Membrane separation treatment is carried out by, for example, pouring the concentrate which is diluted to the appropriate concentration onto ultrafiltration membrane modules with a molecular weight cutoff of 2,000 to 20,000. Impurities permeate the membrane together with water, and pigments including crocin are concentrated. These procedures are repeated, while supplying water, until the desired degree of purity is obtained. Lastly, the liquid is separated and concentrated to prepare a concentrate in which geniposide is significantly reduced.
  • Concentration is carried out according to a common method by using a condensing vessel, which usually results in a concentrate havingmoisture content of about 10 to 80 % byweight , preferably about 15 to 40 % byweight with the color value (E 10% ⁇ cra ) of about 100 to 650, preferably about 400 to 600.
  • crocetin can be obtained by hydrolysis of the said extract, the said concentrate or the concentrate, in which geniposide is significantly reduced.
  • the concentrate is subjected to hydrolysis after, if desired, diluted with water to the appropriate concentration.
  • Hydrolysis is carried out by the action of an acid, an alkali oran appropriatehydrolase.
  • the acid include hydrochloric acid, sulfuri ⁇ acid, phosphoric acid, etc.
  • the alkali include sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc.
  • An example of the hydrolase includes ⁇ -glucosidase, etc.
  • an alkali is preferably used for hydrolysis .
  • the method may follow a common method and is not particularly limited.
  • the reaction solution may or may not be stirred, or may or may not be heated, while preferably it is stirred and heated to proper temperature to accelerate the reaction.
  • an appropriate amount of an aqueous solution of an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid, etc. or an aqueous solution of an organic acid such as citric acid, etc. is added to the reaction solution to adjust the pH to about 4.0 or lower.
  • the reaction solution is added to an aqueous solution of an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid, etc. or an aqueous solution of an organic acid such as citric acid, etc. to adjust the pH to about 4.0 or lower, preferably about 3.0 or lower, so that crocetin is precipitated.
  • a mixture containing crocetin is filtered through filter paper or filter cloth to collect paste-like solidsubstance containingcrocetin.
  • crocetin is precipitated upon initiation of the reaction and becomes a suspension.
  • the mixture containing crocetin is filtered through filter paper or filter cloth to collect paste-like solid substance containing crocetin.
  • Crocetin thus obtained has a relatively low purity, because it includes materials other than crocetin such as lipid and its decomposition products, polyphenols (e.g. chlorogenic acid) or saccharides (e.g. glucose, gentiobiose) which are generated by hydrolysis and not completely removed by water washing. Therefore, it is not appropriate to use such crocetin as it is in cosmetic products, skin cosmetics, foods, health foods or pharmaceutical compositions.
  • the present invention relates to a method for preparing crocetin of high purity by further treating the said crocetin with a specific solvent .
  • the said crocetin is treated with a lower alcohol.
  • the lower alcohol include one member or a mixture of two or more members selected from the group of lower alcohols having 1 to 4 carbon atoms such as methanol, ethanol, propanol, isopropanol, n-butanol, i-butanol, sec-butanol, tert-butanol, etc. , among which methanol is preferably used.
  • the amount of methanol is about 1 to 2000 parts by volume, preferably about 10 to 250 parts by volume, more preferably about 10 to 40 parts by volume relative to 1 part by weight of crocetin.
  • a mixture of the said crocetin and methanol is stirred at about 30 to 65 °C, preferably at about 45 to 50 °C for about 0.5 to 1 hour under gentle reflux. Then the mixture is cooled to room temperature and filtered through filter paper or filter cloth.
  • the filtering method includes suction filtration, pressure filtration or centrifugal separation, etc. Crocetin remaining on filter paper or filter cloth is collected, and the filtrate containing soluble impurities inmethanol is discarded.
  • the said crocetin maybe treatedwith amixed solvent containing about 50% byvolume or more, preferably about 70% by volume or more of lower alcohol .
  • Examples of the solvent to be mixedwith the lower alcohol include solvents having high compatibility with lower alcohol such as water, saturatedorunsaturatedaliphatic alcohols , ketones (e.g. acetone, ethylmethylketone) , ethers (e.g. diethyl ether) , ethyl acetate, and the like.
  • solvents having high compatibility with lower alcohol such as water, saturatedorunsaturatedaliphatic alcohols , ketones (e.g. acetone, ethylmethylketone) , ethers (e.g. diethyl ether) , ethyl acetate, and the like.
  • the mixture of the said crocetin and the mixed solvent containing 50% by volume or more of lower alcohol is stirred at a temperature below the boiling point of the mixed solvent for 0.5 to 1 hour preferably under gentle reflux. Then the mixture is cooledto room temperature and filtered through filter paper or filter cloth. Crocetin remaining on filter paper or filter cloth is collected, and the filtrate containing soluble impurities in the mixed solvent is discarded.
  • the said crocetin which is a hydrolysis product of crocin, is subjected to crystallization procedure in an aprotic solvent which can crystallize crocetin such as dimethylformamide, dimethylsulfoxide, dimethylacetamido, N-methyl-2-pyrrolidone, acetonitorile, ⁇ -butyrolactone, hexamethylphosphoric triamide, sulfolane, 1 , 3-dimethyl-2-imidazolidinone,
  • an aprotic solvent which can crystallize crocetin such as dimethylformamide, dimethylsulfoxide, dimethylacetamido, N-methyl-2-pyrrolidone, acetonitorile, ⁇ -butyrolactone, hexamethylphosphoric triamide, sulfolane, 1 , 3-dimethyl-2-imidazolidinone,
  • N-methylcaprolactam Preferably dimethylformamide, dimethylsulfoxide or a mixture thereof, more preferably dimethylformamide is used.
  • Those aprotic solvents may be used independently or as a mixed solvent of one or more of them.
  • the said aprotic solvents may be mixed with a nonpolar solvent or other solvents as long as the mixture can crystallize crocetin. Examples of such nonpolar solvent include benzene, toluene, hexane, etc., and examples of such other solvents include water, methanol, ethanol, chloroform, etc.
  • the crystallization method may follow a common method and is not particularly limited. That is, the amount of the solvent used may be any amount that can produce a saturated solution at a temperature at which crocetin dissolves, and for example the amount of dimethylformamide relative to 1 part by weight of crocetin is about 10 to 40 parts by volume, preferably about 15 to 20 parts by volume.
  • the mixed solution of the said crocetin and dimethylformamide is heated to between room temperature and 100 °C, preferably about between 50 °C and 80 °C, and stirred for about 0.5 to 1 hour to dissolve crocetin.
  • the solution may be concentrated preferably under vacuum after dissolution.
  • the solution is gradually cooled to room temperature (about 1 °C to 30 °C) or lower after impurities, if present, are removed from the solution by filtration.
  • the solution is allowed to stand calmly preferably at the original temperature to form crystals , then the mixed solution containing formed crocetin crystals is filtered through filter paper or filter cloth. Crocetin remaining on filter paper or filter cloth is collected, and the filtrate containing soluble impurities in dimethylformamide is discarded.
  • dimethylsulfoxide is used, crystals are occasionally not precipitated depending on the amount of the solvent used even if the solution is cooled to room temperature. In such a case, crystals may be precipitated by, for example, adding the appropriate amount of water.
  • resulting crocetin crystals arewashedwithmethanolorethanol, preferablyethanol.
  • the amount of ethanol is about 5 to 80 parts by volume, preferably about 10 to 40 parts by volume relative to 1 part by weight of crocetin crystals. Solvents such as dimethylformamid adhered to the surface of crocetin crystals are removed by washing with ethanol, whichmakes it easier to remove solvents in the finishing operation .
  • the purified crocetin obtained in the first method may be used as starting material in place of the said crocetin.
  • Use of the purified crocetin increases the possibility of obtaining crocetin crystals of higher purity.
  • crocetin with the purity of about 70 % by weight or more, often about 80 % by weight or more can be obtained by the first method
  • crocetin with the purity of about 90 % by weight or more, often about 95 % by weight or more can be obtained by the second method.
  • the color value of the purified crocetin of high purity prepared with crystallization step is measured by the below-mentioned method to result in the value 35,700, based on which the above purity is calculated.
  • Crocetin has been reported to show not only actions on skinas asinglet oxygenscavenger, collagenproduction stimulant and skin immunostimulator as described above, but also physiological actions suchas cholesterol lowering effect , tumor growth inhibiting effect , hepatotoxicity inhibitory effect , etc. Therefore, the purified crocetin of the present invention is useful as a pharmaceutical composition or cosmetic product or skin cosmetics.
  • the crocetin of the present invention maybe usedas ayellowpigment in food including confectioneries , noodles, dairy products, fish paste, pickled vegetables, vinegaredfood, Neri-yokan (thick sweet bean jelly) , Mizu-yokan (soft sweet bean jelly) , Uiro (sweet steamed rice paste) , boiled beans, Neri-uni(paste of seasoned sea-urchin eggs), Furikake (seasoned fish and vegetable flakes), etc.
  • Known pharmaceutical carriers escipients or other additives to be used with crocetin may be chosen by those skilled in the art depending on the types and purposes of the use. More specifically, excipients, disintegrators, binding agents, surfactants, emulsifiers, plasticizers, wetting agents, lubricants, sugars, pH regulators, preservatives, flavoring agents, coloring agents or the like may be exemplified in the case of pharmaceutical compositions or cosmetic products , and various nutrients , vitamins, flavoring agents, coloring agents , antioxidants , flavoring materials for chocolate, cheese, etc., artificial sweeteners or the like may be exemplified in the case of foods or health foods .
  • compositions of the present invention may be administered orally in the form of syrup, powder, granule, pill, tablet, hard capsule, soft capsule or may be administered parenterally in the form of suppository, parenteral injection, infusion, etc., depending on the method and root of administration.
  • crocetin may be appropriately added to produce a cosmetic product in the form of cream, lotion, ointment, liquid formulation, paste, etc.
  • crocetin When crocetin is appliedto foodorhealth food, itmaybe provided in the form of granule, tablet, chewing gum, candy, jelly, beverage, etc. , though the form is not limited to those mentioned above.
  • crocetin With regard to the intake of crocetin, it is advisable to adjust the dosage of crocetin as an active ingredient in a range of about 0.1 mg to 500 mg, preferably about 1 mg to 300 mg, more preferably about 2 mg to 100 mg per a day per a human adult considering the absorption rate in the case of oral formulations , though the intake cannot be generalized because it depends on sex, age, health condition, etc. of those who take crocetin. In the case of parenteral formulations such as injections or infusions, it is advisable to adjust the dosage of crocetin in a range of about 0.1 mg to 100 mg, preferably about 0.1 mg to 50 mg, more preferably about 0.5 mg to 10 mg per a day per a human adult.
  • crocetin is contained in an amount of about 0.001 to 10 % by weight relative to the whole weight of the skin cosmetics.
  • crocetin in the case of food or health food, it is generally advisable to add crocetin in an amount of about 0.00003 to 10 % by weight, preferably about 0.01 to 5 % by weight, relative to the whole weight of the food or health food.
  • compositions, skin cosmetics, cosmeticproducts, foods orhealthfoodswhichcontain crocetin may be administered, used or taken one to several times a day.
  • Color value was measured by the method mentioned below according to "Food Additives Other Than Chemically Synthesized Compounds, voluntary standards (second edition), gardenia yellow” Japan Food Additives Association.
  • the sample is precisely measured in such a way that the measured absorbance thereof falls between 0.3 and 0.7, and then dissolved in Kolthoff buffer (50mM Na 2 CO 3 -50mM Na 2 B0 7 , pHlO.0) to accurately prepare 500 ml of the solution.
  • supersonic treatment is applied for the dissolution.
  • the solution (10 mL) is exactly measured and Kolthoff buffer (50mM Na 2 C0 3 -50mM Na 2 B 4 0 7 , pH 10.0) is added thereto to prepare 50 mL of a test solution.
  • the resulting concentrate was mixed with 40 % by weight of sodium hydroxide solution (17 g) , and the mixed solution was subjected to hydrolysis reaction at 50 °C for 3.5 hours while stirring. After the reaction, the reaction mixture was added to 4 % by weight of aqueous phosphoric acid solution (420 ml) to make it acidic and allowed to stand at room temperature for about 3 hours . The precipitated deposits were collected by centrifugation at 10,000 x g for 10 minutes, and twice subjected to washing with 100 ml of water and the centrifugation. The resulting paste-like solid substance was vacuum-dried at 50 °C for 8 hours to give about 1.2 g of crocetin. The color value (E 10% ⁇ cm ) of the crocetin was about 12,500.
  • Dimethylformamide ( 6.5 ml) was added to 0.15 g of purified crocetin obtained in Example 1, then dissolved at 80 °C while stirring. The insoluble substances were filtered through quantitative filter paper No. 5C, and the filtrate was allowed to stand at 10 °C for 3 days. Next, the mother liquor containing formed crocetin crystals was passed through a sintered glass filter No.3, and the crystals were vacuum-dried at 50 °C after washed with 10 ml of methanol to give about 0.09 g of purified crocetin. The color value (E 10% lcm ) of the purified crocetin was about 35,700.
  • Example 4 Melting point determination and elemental analysis of the crystals obtained in Example 4 were carried out by an external institution. The results are shown below. Melting point: 285 °C to 286 °C
  • crocetinofhighpurity is easily prepared in an industrial manner, and it is preferably applied to cosmetic products , skin cosmetics , pharmaceutical compositions and the like.
  • the unpleasant taste and off-flavor of the crocetin are significantly decreased because of the purification, which makes it possible for such crocetin to be used in a broader range of food or health food.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides an easily operated, industrially advantageous method for the production of crocetin. In more detail, the present invention relates to a method for the purification of crocetin, which comprises treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol and removing a soluble component in the solvent. The present invention also relates to a method for the purification of crocetin, which comprises dissolving crocetin obtained by hydrolysis of crocin, which exists in a plant extract, into an aprotic solvent which can crystallize crocetin and crystallizing crocetin from the solvent. The present invention makes it possible to efficiently prepare a desired purified crocetin of high purity. The purified crocetin is useful as a pharmaceutical composition, cosmetic product or skin cosmetics and can be used as an additive in food and health food.

Description

Description
METHOD FOR THE PURIFICATION OF CROCETIN
Technical Field
The present invention relates to a method for the purification of crocetin which is obtained by hydrolysis of crocin existing in a plant extract.
Background Art
Crocin, which is extracted from dried fruits of gardenia or fromdried saffron stigma, is digentiobiose ester of crocetin. Crocetin is obtained by hydrolyzing crocin with alkali, etc. to remove digentiobiose of crocin (c.f . , for example, non-patent literature 1 ) .
In addition to the above, there has been proposed a method for the production of crocetin, in which crocin is hydrolyzed using an enzyme (c.f., for example. Patent literature 1).
Crocin is water-soluble and used as a primary color component of gardenia yellow for coloring a wide range of foods in Japan. On the other hand, crocetin is insoluble in water and soluble in diluted alkaline water, and thus it has been limitedly used as a coloring agent for Chinese noodle (c.f., for example, patent literature 2) or soft drinks (c.f., for example, patent literature 3), etc.
As a result of the recent progress in the studies on the functions of carotenoid pigments , there have been reported the effects of crocetin on skin as a singlet oxygen scavenger (c.f. , for example, patent literature 4), collagen production stimulants (c.f., for example, patent literature 5), and skin immunostimulators (c.f., for example, patent literature 6). Moreover, physiological actions of crocetin including cholesterol lowering effect, tumor growth inhibiting effect, hepatotoxicity inhibitory effect , etc. have been reported (see, for example, non patent literature 2 ) .
In order to utilize crocetin in skin cosmetics or pharmaceutical compositions aiming for such actions or effects, crocetin of high purity prepared not only byhydrolysis of crocin but alsobytheremoval of impurities forpurification is desired.
Although there have been disclosed methods for the preparation of crocetin in the laboratory to obtain a sample for analysis ( see, for example, non patent literature 3,4,5,6) , manipulation and process control of those methods are complex, which means they are inappropriate for industrial production. Therefore, an industrially advantageous method for producing crocetin of high purity in an industrial scale at low cost has not been known yet .
(Patent literature 1) Japanese Unexamined Patent Publication No. H07-018194
(Patent literature 2) Japanese Unexamined Patent Publication No. S54-064652
(Patent literature 3) Japanese Unexamined Patent Publication No. H06-248193
(Patent literature 4) Japanese Unexamined Patent Publication No. H05-320036
(Patent literature 5) Japanese Unexamined Patent Publication No. H07-285846 (Patent literature 6) Japanese Unexamined Patent Publication No. Hll-246396
(Non-patent literature 1) TANIMURAAkio, et al. , "Handbook of natural coloring agents", Korin Publishing Co.,Ltd., June 25, 1979, p. 215
(Non-patent literature 2) KON Masayo, "gardenia carotenoidpigment" , Bulletin of FukuokaWomen' s JuniorCollege, 1999, No. 57, p.31-34
(Non-patent literature 3) KAMIKURAMieko, et al. , "Journal of the Food Hygienic Society of Japan", 1985, 26, No.2, p.151 (Non-patent literature 4) J.Agric.Food Chem. , 1996, 44, No.9, p.2613, left column, line46-61
(Non-patent literature 5) SpectrochemicaActaPart A, 1998, 54, p.654, left column, lines 16-24 (Non-patent literature 6) J.Food Sci.Technol. , 2001, 38, No.4, p.325, left column, lines 36-42
Disclosure of the Invention
An object of the present invention is to provide an easily operated, industrially advantageous method for the production of crocetin.
The present inventors had conducted intensive investigations to solve the above mentioned problems and, as a result, they have found that a desired crocetin of high purity canbe effectivelypreparedwhen crocetin containing impurities , which is obtained by hydrolysis of crocin existing in a plant extract, is treated with a specific organic solvent. Based on this finding, the present inventors have achieved the present invention. Thus, the present invention relates to the following (1) to (9).
(1) A method for the purification of crocetin, which comprises the steps of (a) treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol; and (b) removing a soluble component in the solvent.
(2) A method for the purification of crocetin, which comprises the steps of
(a) dissolving crocetin obtained by hydrolysis of crocin, which exists in a plant extract, into an aprotic solvent which can crystallise crocetin; and
(b) crystallizing crocetin from the solvent. ( 3 ) The method for the purification of crocetin according to the above (2) , wherein an aprotic solvent is dimethylformamide or dimethylsulfoxide or a mixture thereof .
(4) A method for the purification of crocetin, which comprises the steps of (a) treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol to remove a soluble component in the solvent; and (b) crystallizing the above treated crocetin from an aprotic solvent which can crystallize crocetin.
( 5) The method for the purification of crocetin according to the above ( 4 ) , wherein an aprotic solvent is dimethylformamide or dimethylsulfoxide or a mixture thereof.
(6) A purified crocetin which is prepared by the method described in any of the above ( 1 ) to ( 5 ) .
(7) A purified crocetin, of which color value (E10%ιcm) is in a range of 27,000 to 35,700.
(8) A cosmetic product or pharmaceutical composition, which comprises the purified crocetin described in the above
(6) or (7).
(9) Food or health food, which comprises the purified crocetin described in the above (6 ) or ( 7 ) .
Best Mode for Carrying Out the Invention
Crocin, which is ayellow carotenoid pigment , is contained in dried fruits of gardenia (rubiaceae) (Gardenia augusta ERRIL var. grandiflora HORT., Gardenia jasminoides ELLIS) and dried saffron stigma, and the fruits of gardenia are preferably used as an industrial material to obtain crocin.
According to the present invention, crocin is extracted frompulverized, driedfruits of gardeniawithwater or an alcohol or a mixture thereof . Although water is pre erable as an extracting solvent, the extraction rate is low. Thus, usually amixture ofwater andan alcohol is usedfor industrial purposes . Examples of the alcohol include ethanol, methanol and the like, among which methanol is preferably used. The preferable mixing ratio of an alcohol relative to the mixture of the alcohol and water is, for example, not less than 50% by volume. After extraction, the extract is collected all together and filtered through filter paper or filter cloth optionally using a filter aid such as diatomite . The filtrate is concentrated to recover alcohol, whereby a concentrate can be obtained.
In the present invention, it is preferable to further remove an iridoid glycoside such as geniposide, etc. from the extract of gardenia by absorbent resin treatment or membrane separation treatment, etc.
Absorbent resin treatment is carried out in such a manner that acolumnis filledwithaporous absorbent andthe concentrate which is diluted to the appropriate concentration is supplied to the column. For example, after pouring a pigment solution (i.e. the above diluted concentrate containing crocin) until columns are saturated with the pigment, impurities are washed out with water or a mixture of a dilute alcohol and water. Then, the pigments were desorbed i.e. eluted by 50 to 70 % by volume of alcohol and the eluted solution is concentrated to give a concentrate in which geniposide is significantly reduced. Examples of the alcohol include a lower alcohol having 1 to 4 carbon atoms such as methanol, ethanol, propanol, isopropanol, n-butanol, i-butanol, sec-butanol, tert-butanol, etc., among which ethanol is preferably used. Examples of the porous absorbent include Amberlite XAD-4, Jlmberlite XAD-7 (Trademark: Organo Corporation), Diaion HP-20, HP-21, HP-40 (Trademark: Mitsubishi Chemical Corporation), and the like.
Membrane separation treatment is carried out by, for example, pouring the concentrate which is diluted to the appropriate concentration onto ultrafiltration membrane modules with a molecular weight cutoff of 2,000 to 20,000. Impurities permeate the membrane together with water, and pigments including crocin are concentrated. These procedures are repeated, while supplying water, until the desired degree of purity is obtained. Lastly, the liquid is separated and concentrated to prepare a concentrate in which geniposide is significantly reduced.
Concentration is carried out according to a common method by using a condensing vessel, which usually results in a concentrate havingmoisture content of about 10 to 80 % byweight , preferably about 15 to 40 % byweight with the color value (E10%ιcra) of about 100 to 650, preferably about 400 to 600.
In the present invention, crocetin can be obtained by hydrolysis of the said extract, the said concentrate or the concentrate, in which geniposide is significantly reduced. During the process, the concentrate is subjected to hydrolysis after, if desired, diluted with water to the appropriate concentration.
Hydrolysis is carried out by the action of an acid, an alkali oran appropriatehydrolase. Examples of the acidinclude hydrochloric acid, sulfuriσ acid, phosphoric acid, etc. and examples of the alkali include sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc. An example of the hydrolase includes β-glucosidase, etc.
In industrial practice, usually an alkali is preferably used for hydrolysis . The method may follow a common method and is not particularly limited. During hydrolysis, the reaction solution may or may not be stirred, or may or may not be heated, while preferably it is stirred and heated to proper temperature to accelerate the reaction. After hydrolysis by an alkali, an appropriate amount of an aqueous solution of an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid, etc. or an aqueous solution of an organic acid such as citric acid, etc. is added to the reaction solution to adjust the pH to about 4.0 or lower. preferably about 3.0 or lower, or alternatively, the reaction solution is added to an aqueous solution of an inorganic acid such as hydrochloric acid, sulfuric acid, phosphoric acid, etc. or an aqueous solution of an organic acid such as citric acid, etc. to adjust the pH to about 4.0 or lower, preferably about 3.0 or lower, so that crocetin is precipitated. A mixture containing crocetin is filtered through filter paper or filter cloth to collect paste-like solidsubstance containingcrocetin. When an acid is used for hydrolysis, crocetin is precipitated upon initiation of the reaction and becomes a suspension. After the reaction, the mixture containing crocetin is filtered through filter paper or filter cloth to collect paste-like solid substance containing crocetin.
The said solid substance is washed with sufficient amount of water to remove acid, neutral salt or impurities derived from the raw materials which are attached to the surface, then remaining water is removed by evaporation using, for example, a vacuum shelf dryer at 50 °C or lower temperature preferably in the presence of nitrogen gas . Crocetin thus obtained, however, has a relatively low purity, because it includes materials other than crocetin such as lipid and its decomposition products, polyphenols (e.g. chlorogenic acid) or saccharides (e.g. glucose, gentiobiose) which are generated by hydrolysis and not completely removed by water washing. Therefore, it is not appropriate to use such crocetin as it is in cosmetic products, skin cosmetics, foods, health foods or pharmaceutical compositions.
The present invention relates to a method for preparing crocetin of high purity by further treating the said crocetin with a specific solvent .
According to the first method of the present invention, the said crocetin is treated with a lower alcohol. Examples of the lower alcohol include one member or a mixture of two or more members selected from the group of lower alcohols having 1 to 4 carbon atoms such as methanol, ethanol, propanol, isopropanol, n-butanol, i-butanol, sec-butanol, tert-butanol, etc. , among which methanol is preferably used. The amount of methanol is about 1 to 2000 parts by volume, preferably about 10 to 250 parts by volume, more preferably about 10 to 40 parts by volume relative to 1 part by weight of crocetin.
A mixture of the said crocetin and methanol is stirred at about 30 to 65 °C, preferably at about 45 to 50 °C for about 0.5 to 1 hour under gentle reflux. Then the mixture is cooled to room temperature and filtered through filter paper or filter cloth. The filtering method includes suction filtration, pressure filtration or centrifugal separation, etc. Crocetin remaining on filter paper or filter cloth is collected, and the filtrate containing soluble impurities inmethanol is discarded. In the method of the present invention, the said crocetin maybe treatedwith amixed solvent containing about 50% byvolume or more, preferably about 70% by volume or more of lower alcohol . Examples of the solvent to be mixedwith the lower alcohol include solvents having high compatibility with lower alcohol such as water, saturatedorunsaturatedaliphatic alcohols , ketones (e.g. acetone, ethylmethylketone) , ethers (e.g. diethyl ether) , ethyl acetate, and the like.
The mixture of the said crocetin and the mixed solvent containing 50% by volume or more of lower alcohol is stirred at a temperature below the boiling point of the mixed solvent for 0.5 to 1 hour preferably under gentle reflux. Then the mixture is cooledto room temperature and filtered through filter paper or filter cloth. Crocetin remaining on filter paper or filter cloth is collected, and the filtrate containing soluble impurities in the mixed solvent is discarded.
Theremainingsolvent is removedfromthe crocetinpurified by the above method using, for example, a vacuum shelf dryer at a temperature about 80 °C or lower, preferably about 60 °C or lower, more preferably about 50 °C or lower, preferably in the presence of nitrogen gas .
According to the second method of the present invention, the said crocetin, which is a hydrolysis product of crocin, is subjected to crystallization procedure in an aprotic solvent which can crystallize crocetin such as dimethylformamide, dimethylsulfoxide, dimethylacetamido, N-methyl-2-pyrrolidone, acetonitorile, γ-butyrolactone, hexamethylphosphoric triamide, sulfolane, 1 , 3-dimethyl-2-imidazolidinone,
N-methylcaprolactam, acetone, tetrahydrofuran, etc. Preferably dimethylformamide, dimethylsulfoxide or a mixture thereof, more preferably dimethylformamide is used. Those aprotic solvents may be used independently or as a mixed solvent of one or more of them. The said aprotic solvents may be mixed with a nonpolar solvent or other solvents as long as the mixture can crystallize crocetin. Examples of such nonpolar solvent include benzene, toluene, hexane, etc., and examples of such other solvents include water, methanol, ethanol, chloroform, etc.
The crystallization method may follow a common method and is not particularly limited. That is, the amount of the solvent used may be any amount that can produce a saturated solution at a temperature at which crocetin dissolves, and for example the amount of dimethylformamide relative to 1 part by weight of crocetin is about 10 to 40 parts by volume, preferably about 15 to 20 parts by volume.
The mixed solution of the said crocetin and dimethylformamide is heated to between room temperature and 100 °C, preferably about between 50 °C and 80 °C, and stirred for about 0.5 to 1 hour to dissolve crocetin. In the above dissolution process, it is preferable to dissolve crocetin in an aprotic solvent until crocetin is saturated in the solution. In the case where the concentration of crocetin does not reach saturation point during dissolution, the solution may be concentrated preferably under vacuum after dissolution. The solution is gradually cooled to room temperature (about 1 °C to 30 °C) or lower after impurities, if present, are removed from the solution by filtration. The solution is allowed to stand calmly preferably at the original temperature to form crystals , then the mixed solution containing formed crocetin crystals is filtered through filter paper or filter cloth. Crocetin remaining on filter paper or filter cloth is collected, and the filtrate containing soluble impurities in dimethylformamide is discarded. When dimethylsulfoxide is used, crystals are occasionally not precipitated depending on the amount of the solvent used even if the solution is cooled to room temperature. In such a case, crystals may be precipitated by, for example, adding the appropriate amount of water. According to the present invention, resulting crocetin crystals arewashedwithmethanolorethanol, preferablyethanol. The amount of ethanol is about 5 to 80 parts by volume, preferably about 10 to 40 parts by volume relative to 1 part by weight of crocetin crystals. Solvents such as dimethylformamid adhered to the surface of crocetin crystals are removed by washing with ethanol, whichmakes it easier to remove solvents in the finishing operation .
In the second method, the purified crocetin obtained in the first method may be used as starting material in place of the said crocetin. Use of the purified crocetin increases the possibility of obtaining crocetin crystals of higher purity.
Theremaining solvent is removedfromthecrocetincrystals purified by the above method using, for example, a vacuum shelf dryer at a temperature about 80 °C or lower, preferably about
60 °C or lower, more preferably about 50 °C or lower, preferably in the presence of nitrogen gas .
Accordingto themethods of thepresent invention, crocetin with the purity of about 70 % by weight or more, often about 80 % by weight or more, can be obtained by the first method, and crocetin with the purity of about 90 % by weight or more, often about 95 % by weight or more, can be obtained by the second method. Meanwhile, in the present invention, the color value of the purified crocetin of high purity prepared with crystallization step is measured by the below-mentioned method to result in the value 35,700, based on which the above purity is calculated.
Crocetin has been reported to show not only actions on skinas asinglet oxygenscavenger, collagenproduction stimulant and skin immunostimulator as described above, but also physiological actions suchas cholesterol lowering effect , tumor growth inhibiting effect , hepatotoxicity inhibitory effect , etc. Therefore, the purified crocetin of the present invention is useful as a pharmaceutical composition or cosmetic product or skin cosmetics. Also, the crocetin of the present invention maybe usedas ayellowpigment in food including confectioneries , noodles, dairy products, fish paste, pickled vegetables, vinegaredfood, Neri-yokan (thick sweet bean jelly) , Mizu-yokan (soft sweet bean jelly) , Uiro (sweet steamed rice paste) , boiled beans, Neri-uni(paste of seasoned sea-urchin eggs), Furikake (seasoned fish and vegetable flakes), etc. or in health food, when it is made into cyclodextrin clathrates as disclosed in Japanese UnexaminedPatent Publication No.H6-248193 or Japanese Unexamined Patent Publication NO.H7-23736, spray-dried powder as disclosedin Japanese PublishedPatent No . S56-25097 , emulsion or lysate (c.f. Non-patent literature 2).
Known pharmaceutical carriers , escipients or other additives to be used with crocetin may be chosen by those skilled in the art depending on the types and purposes of the use. More specifically, excipients, disintegrators, binding agents, surfactants, emulsifiers, plasticizers, wetting agents, lubricants, sugars, pH regulators, preservatives, flavoring agents, coloring agents or the like may be exemplified in the case of pharmaceutical compositions or cosmetic products , and various nutrients , vitamins, flavoring agents, coloring agents , antioxidants , flavoring materials for chocolate, cheese, etc., artificial sweeteners or the like may be exemplified in the case of foods or health foods . The pharmaceutical compositions of the present invention may be administered orally in the form of syrup, powder, granule, pill, tablet, hard capsule, soft capsule or may be administered parenterally in the form of suppository, parenteral injection, infusion, etc., depending on the method and root of administration. In the case of cosmetic product, crocetin may be appropriately added to produce a cosmetic product in the form of cream, lotion, ointment, liquid formulation, paste, etc. When crocetin is appliedto foodorhealth food, itmaybe provided in the form of granule, tablet, chewing gum, candy, jelly, beverage, etc. , though the form is not limited to those mentioned above.
With regard to the intake of crocetin, it is advisable to adjust the dosage of crocetin as an active ingredient in a range of about 0.1 mg to 500 mg, preferably about 1 mg to 300 mg, more preferably about 2 mg to 100 mg per a day per a human adult considering the absorption rate in the case of oral formulations , though the intake cannot be generalized because it depends on sex, age, health condition, etc. of those who take crocetin. In the case of parenteral formulations such as injections or infusions, it is advisable to adjust the dosage of crocetin in a range of about 0.1 mg to 100 mg, preferably about 0.1 mg to 50 mg, more preferably about 0.5 mg to 10 mg per a day per a human adult. In the case of skin cosmetics, it is preferable that crocetin is contained in an amount of about 0.001 to 10 % by weight relative to the whole weight of the skin cosmetics. In the case of food or health food, it is generally advisable to add crocetin in an amount of about 0.00003 to 10 % by weight, preferably about 0.01 to 5 % by weight, relative to the whole weight of the food or health food.
Meanwhile, the above pharmaceutical compositions, skin cosmetics, cosmeticproducts, foods orhealthfoodswhichcontain crocetin may be administered, used or taken one to several times a day.
Examples
The present invention will be specifically illustrated according to examples . <Measuring method of color Value>
Color value was measured by the method mentioned below according to "Food Additives Other Than Chemically Synthesized Compounds, voluntary standards (second edition), gardenia yellow" Japan Food Additives Association. The sample is precisely measured in such a way that the measured absorbance thereof falls between 0.3 and 0.7, and then dissolved in Kolthoff buffer (50mM Na2CO3-50mM Na2B07, pHlO.0) to accurately prepare 500 ml of the solution. When the sample hardly dissolves, supersonic treatment is applied for the dissolution. The solution (10 mL) is exactly measured and Kolthoff buffer (50mM Na2C03-50mM Na2B407, pH 10.0) is added thereto to prepare 50 mL of a test solution. Kolthoff buffer (50mM Na2CO3-50mM Na2B407, pHlO.0) is used as a control. Absorbance(A) that is the maximum absorbance at around 420 nm through 1 cm liquid length is measured, and the color value is calculated by the following formula. Color Value (E10%ιcm) =(A x 250) ÷ amount of sample collected(g)
Reference Example 1 A mixed solution (300 ml) of methanol and water (1:1 by volume) was addedto 150 gofpulverized, driedfruits of gardenia, and the mixture was stirred at room temperature for 3 hours, followed by suction filtration. To the extraction residue was added 300 ml of a mixed solution of methanol and water (1:1 by volume) . The mixture was stirred at room temperature for 30 minutes andsubjectedto suctionfiltration, andtheseprocedures were repeated once again to collect the total volume of about 900 ml of the extract as filtrate. The extract was concentrated using a rotary evaporator under vacuum at 60 °C to give about 50 g of a concentrate containing crocin (color value (E10% lcm)=573).
The resulting concentrate was mixed with 40 % by weight of sodium hydroxide solution (17 g) , and the mixed solution was subjected to hydrolysis reaction at 50 °C for 3.5 hours while stirring. After the reaction, the reaction mixture was added to 4 % by weight of aqueous phosphoric acid solution (420 ml) to make it acidic and allowed to stand at room temperature for about 3 hours . The precipitated deposits were collected by centrifugation at 10,000 x g for 10 minutes, and twice subjected to washing with 100 ml of water and the centrifugation. The resulting paste-like solid substance was vacuum-dried at 50 °C for 8 hours to give about 1.2 g of crocetin. The color value (E10%ιcm) of the crocetin was about 12,500.
Example 1
Methanol (250 ml) was added to 1 g of crocetin obtained in the same manner as described in Reference Example 1, and the mixture was stirred at 50 °C for 30 minutes. Then the mixture was centrifuged at 10,000 x g for 10 minutes to collect deposits and the resulting paste-like solid substance was vacuum-dried at 50 °C for 8 hours to give about 0.32 g of purified crocetin. The color value (E10%ιCm) of the purified crocetin was about 30,100.
Example 2
A mixture (250 ml) of methanol and water (4:1 by volume) was added to 1 g of crocetin obtained in the same manner as described in Reference Example 1, and the mixture was stirred at 50 °C for 30 minutes. Then the mixture was centrifuged at 10,000 x g for 10 minutes to collect solid substance and the resulting paste-like solid substance was vacuum-dried at 50 °C for 8 hours to give about 0.39 g of purified crocetin . The color value (E10% lcm) of the purified crocetin was about 27,000.
Esample 3
Dimethylformamide (18 ml) was added to 1 g of crocetin obtained in the same manner as described in Reference Example 1, then dissolved at 80 °C. The insoluble substances were filtered through quantitative filter paper (No. 5C, Advantec Toyo Kaisha, Ltd. ) and the filtrate was allowed to stand at 10 °C for 3 days . Next , themother liquor containingformedcrocetin crystals was passed through a sintered glass filter No.3, and the crystals were vacuum-dried at 50 °C after washed with 20 ml of methanol to give about 0.16 g of purified crocetin. The color value (E10%ιcm) of the purified crocetin was about 34,200. Example 4
Dimethylformamide ( 6.5 ml) was added to 0.15 g of purified crocetin obtained in Example 1, then dissolved at 80 °C while stirring. The insoluble substances were filtered through quantitative filter paper No. 5C, and the filtrate was allowed to stand at 10 °C for 3 days. Next, the mother liquor containing formed crocetin crystals was passed through a sintered glass filter No.3, and the crystals were vacuum-dried at 50 °C after washed with 10 ml of methanol to give about 0.09 g of purified crocetin. The color value (E10% lcm) of the purified crocetin was about 35,700.
Test Example 1
Melting point determination and elemental analysis of the crystals obtained in Example 4 were carried out by an external institution. The results are shown below. Melting point: 285 °C to 286 °C
Elemental analysis: Carbon 72.60 %, Hydrogen 7.51 %,
Oxygen 19.89 %
The above results show that the data of said crystals are identical with those described in literatures .
Industrial Applicability Accordingto thepresent invention, crocetinofhighpurity is easily prepared in an industrial manner, and it is preferably applied to cosmetic products , skin cosmetics , pharmaceutical compositions and the like. The unpleasant taste and off-flavor of the crocetin are significantly decreased because of the purification, which makes it possible for such crocetin to be used in a broader range of food or health food.

Claims

1. A method for the purification of crocetin, which comprises the steps of (a) treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol; and (b) removing a soluble component in the solvent.
2. A method for the purification of crocetin, which comprises the steps of
(a) dissolving crocetin obtained by hydrolysis of crocin, which exists in a plant extract, into an aprotic solvent which can crystallize crocetin; and (b) crystallizing crocetin from the solvent.
3. The method for the purification of crocetin according to claim 2 , wherein an aprotic solvent is dimethylformamide or dimethylsulfoxide or a mixture thereof .
4. A method for the purification of crocetin, which comprises the steps of
(a) treating crocetin obtained by hydrolysis of crocin, which exists in a plant extract, with lower alcohol or a mixed solvent containing 50% by volume or more of lower alcohol to remove a soluble component in the solvent; and
(b) crystallizing the above treated crocetin from an aprotic solvent which can crystallize crocetin.
5. The method for the purification of crocetin according to claim 4 , wherein an aprotic solvent is dimethylformamide or dimethylsulfoxide or a mixture thereof.
6. A purified crocetin which is preparedby the method described in any of claims 1 to 5.
7. A purified crocetin, of which color value (E10% lcm) is in a range of 27,000 to 35,700.
8. A cosmetic product or pharmaceutical composition, which comprises the purified crocetin described in claim 6 or 7.
9. Food or health food, which comprises the purified crocetin described in claim 6 or 7.
PCT/JP2004/002693 2003-03-07 2004-03-03 Method for the purification of crocetin Ceased WO2004078695A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003-061550 2003-03-07
JP2003061550A JP2004269663A (en) 2003-03-07 2003-03-07 Crocetin purification method

Publications (1)

Publication Number Publication Date
WO2004078695A1 true WO2004078695A1 (en) 2004-09-16

Family

ID=32958963

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/002693 Ceased WO2004078695A1 (en) 2003-03-07 2004-03-03 Method for the purification of crocetin

Country Status (2)

Country Link
JP (1) JP2004269663A (en)
WO (1) WO2004078695A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101811956A (en) * 2010-04-15 2010-08-25 施冬云 Preparation method and application of trans-crocetin
WO2010094745A1 (en) * 2009-02-18 2010-08-26 Omnica Gmbh Hydrolysate of crocin
CN102432455A (en) * 2011-12-14 2012-05-02 广西大学 Method for preparing crocetin and crocin
CN103073417A (en) * 2013-03-04 2013-05-01 苏州衷中医药科技有限公司 Preparation method for high-purity trans-crocetin
CN103601764A (en) * 2013-11-26 2014-02-26 威海东宝制药有限公司 Purification and separation technology of crocin in gardenia extract
CN103641705A (en) * 2013-12-02 2014-03-19 威海东宝制药有限公司 Method for extracting crocetin from gardenia fruit
US9211298B2 (en) 2012-11-16 2015-12-15 Song Gao Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
CN105503968A (en) * 2015-12-02 2016-04-20 武汉绿孚生物工程有限责任公司 Method for separation and purification of crocin and crocetion from gardenia yellow pigment
CN108218692A (en) * 2018-02-26 2018-06-29 南阳泰瑞生物科技股份有限公司 Utilize the method for cape jasmine fruit production crocetin
CN109232230A (en) * 2018-10-31 2019-01-18 湖南中茂生物科技有限公司 A method of extracting crocin from fresh gardenia
KR20190095050A (en) * 2018-02-06 2019-08-14 이석렬 Production Method of Crocetin and Health Supplement for Appetite Suppression Comprising Crocetin as an Active Ingredient
WO2021114089A1 (en) * 2019-12-10 2021-06-17 Hangzhou Menglanruisi Biotechnology Co., Ltd. Methods of using crocetin in treating solid tumors
CN116019802A (en) * 2023-03-07 2023-04-28 西南交通大学 Application of crocetin in preparation of medicine for treating and preventing cerebral ischemic diseases
CN116023255A (en) * 2021-10-26 2023-04-28 广州博济医药生物技术股份有限公司 Preparation method of sodium crocetin
CN117049960A (en) * 2022-05-04 2023-11-14 鼎赫生物科技股份有限公司 Preparation method of crocetin and application of crocetin in antioxidation and eye protection

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677393B2 (en) * 2006-10-31 2011-04-27 理研ビタミン株式会社 Purified gardenia extract
JP5491133B2 (en) * 2009-11-05 2014-05-14 理研ビタミン株式会社 Dipeptidyl peptidase IV inhibitor
JP5706620B2 (en) * 2010-02-16 2015-04-22 グリコ栄養食品株式会社 13-cis-crocetin-rich pigment composition and method for producing the same
JP5677126B2 (en) * 2011-02-18 2015-02-25 花王株式会社 Tyrosinase activity inhibitor and whitening cosmetics
JP2013067592A (en) * 2011-09-26 2013-04-18 Riken Vitamin Co Ltd Oral skin protecting agent
JP5801971B2 (en) * 2015-01-14 2015-10-28 グリコ栄養食品株式会社 13-cis-crocetin-rich pigment composition and method for producing the same
JP6574360B2 (en) * 2015-09-02 2019-09-11 理研ビタミン株式会社 Determination of crocetin
JP7458046B2 (en) * 2020-02-12 2024-03-29 石川県公立大学法人 Method for producing apocarotenoids

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050574A1 (en) * 1997-05-02 1998-11-12 Dsm N.V. Isolation of carotenoid crystals from microbial biomass
US6060511A (en) * 1995-10-05 2000-05-09 Gainer; John L. Trans-sodium crocetinate, methods of making and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060511A (en) * 1995-10-05 2000-05-09 Gainer; John L. Trans-sodium crocetinate, methods of making and methods of use thereof
WO1998050574A1 (en) * 1997-05-02 1998-11-12 Dsm N.V. Isolation of carotenoid crystals from microbial biomass

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
H. RÖMPP: "RÖmpp-Lexikon Chemie - "Crocetin, see Volume 2. Cm-G", 1997, GEORG THIEME VERLAG, STUTTGART (GERMANY), XP002284384, 2 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010094745A1 (en) * 2009-02-18 2010-08-26 Omnica Gmbh Hydrolysate of crocin
US8569247B2 (en) 2009-02-18 2013-10-29 Omnica Gmbh Hydrolysate of crocin
CN101811956A (en) * 2010-04-15 2010-08-25 施冬云 Preparation method and application of trans-crocetin
CN101811956B (en) * 2010-04-15 2013-04-17 施冬云 Preparation method of trans-crocetin
CN102432455A (en) * 2011-12-14 2012-05-02 广西大学 Method for preparing crocetin and crocin
US9211298B2 (en) 2012-11-16 2015-12-15 Song Gao Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
CN103073417B (en) * 2013-03-04 2015-09-02 苏州衷中医药科技有限公司 The preparation method of high-purity trans-crocetin
CN103073417A (en) * 2013-03-04 2013-05-01 苏州衷中医药科技有限公司 Preparation method for high-purity trans-crocetin
CN103601764A (en) * 2013-11-26 2014-02-26 威海东宝制药有限公司 Purification and separation technology of crocin in gardenia extract
CN103641705A (en) * 2013-12-02 2014-03-19 威海东宝制药有限公司 Method for extracting crocetin from gardenia fruit
CN105503968A (en) * 2015-12-02 2016-04-20 武汉绿孚生物工程有限责任公司 Method for separation and purification of crocin and crocetion from gardenia yellow pigment
KR20190095050A (en) * 2018-02-06 2019-08-14 이석렬 Production Method of Crocetin and Health Supplement for Appetite Suppression Comprising Crocetin as an Active Ingredient
KR102041036B1 (en) * 2018-02-06 2019-11-05 이석렬 Production Method of Crocetin and Health Supplement for Appetite Suppression Comprising Crocetin as an Active Ingredient
CN108218692A (en) * 2018-02-26 2018-06-29 南阳泰瑞生物科技股份有限公司 Utilize the method for cape jasmine fruit production crocetin
CN109232230A (en) * 2018-10-31 2019-01-18 湖南中茂生物科技有限公司 A method of extracting crocin from fresh gardenia
WO2021114089A1 (en) * 2019-12-10 2021-06-17 Hangzhou Menglanruisi Biotechnology Co., Ltd. Methods of using crocetin in treating solid tumors
CN116023255A (en) * 2021-10-26 2023-04-28 广州博济医药生物技术股份有限公司 Preparation method of sodium crocetin
CN117049960A (en) * 2022-05-04 2023-11-14 鼎赫生物科技股份有限公司 Preparation method of crocetin and application of crocetin in antioxidation and eye protection
CN116019802A (en) * 2023-03-07 2023-04-28 西南交通大学 Application of crocetin in preparation of medicine for treating and preventing cerebral ischemic diseases

Also Published As

Publication number Publication date
JP2004269663A (en) 2004-09-30

Similar Documents

Publication Publication Date Title
WO2004078695A1 (en) Method for the purification of crocetin
RU2433824C2 (en) Products of connection of sugars to flavonoids, method of their obtaining and application
US20090324787A2 (en) DEODORIZED PLANT COLORANT DERIVED FROM IPOMOEA BATATAS (as amended)
EP0449332B1 (en) Glucosyltransferase inhibitors, as well as dental caries prevention methods and anticarious foods using the same
JP2005170837A (en) Seaweed extract and saccharide hydrolase inhibitor containing the same
JPH0532909A (en) Anti-fading agent for dye
JP2000201650A (en) Hair-restoring food and oral hair-restoring agent
JP2000351801A (en) High purity fucoidan and method for producing the same
JP5583422B2 (en) Crocetin composition
JP5410734B2 (en) Process for producing refined sake enzyme
JP4688795B2 (en) Preparation method of banaba extract
JPH0763294B2 (en) Anti-cariogenic food
JP2002542152A (en) Soluble group IA and IIA metal double salts of (-) hydroxycitric acid
JP2005082546A (en) α-Glucosidase inhibitor
JP2007112931A (en) Blue medium manufacturing method
JP6029390B2 (en) Method for producing xanthohumol / cyclodextrin inclusion complex-containing composition and use thereof
JP5491133B2 (en) Dipeptidyl peptidase IV inhibitor
JP2005118015A (en) Black soybean extract and method for preparing the same
JP4961465B2 (en) Method for preventing precipitation in red radish pigment solution and red radish pigment solution
JP2005225842A (en) Brain function improver
JP2013201999A (en) Gardenia red composition
CN113735919B (en) Method for preparing naringin dihydrochalcone sweetener by adding hydrogen into pummelo peel extract and prepared naringin dihydrochalcone sweetener
KR100511515B1 (en) The Emulsification of Aralia elata Seemnn and Pueraria thunbergina Extracts
JP4961089B2 (en) Red radish pigment preparation
JP5248755B2 (en) Angiotensin I-converting enzyme inhibitor and method for producing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase